PETER MUNK CARDIAC CENTRE

Revolutionizing Cardiovascular Care

Whether it’s developed at birth or later in life, a result of lifestyle or genetics, detectable early or late, the fact remains: heart disease is the leading cause of death worldwide.

The Peter Munk Cardiac Centre is the premier destination to treat heart disease in Canada. We have over 163,000 out-patient visits a year and multidisciplinary teams perform more

than 2,500 cardiac and vascular surgeries, 7,800 interventional cardiology procedures, 35 heart transplants, and 45 mechanical heart support implants annually. The Peter Munk Cardiac Centre is harnessing the power of the latest research breakthroughs and technological advancements, including artificial intelligence and machine learning, to deliver the strongest patient outcomes.

Dr. Tirone David, one of the world’s foremost experts in cardiac surgery, has performed open-heart surgery on more than 15,000 patients and developed 17 life-saving procedures over his time at the Peter Munk Cardiac Centre. The “David Procedure,” as it is commonly known, is just one example, where the enlarged aorta near the heart is removed while preserving the normal aortic valve. With an illustrious career spanning four decades, Dr. David has accumulated a wealth of data on the long-term consequences of these operations, which have the potential to guide future treatment strategies.

The passion and intrigue Dr. David felt the first time he stepped into the operating room is even stronger today. His goal is to build a Heart Valve Research Laboratory specifically devoted to studying the molecular basis of inherited heart valve diseases. With support from Golf for Heart 2020, a new laboratory would promote multidisciplinary care for patients, including those with mitral valve prolapse, aortic root aneurysms, and those born with a bicuspid aortic valve. It will also recruit scientists to perform extensive clinical evaluations, genetic testing, and cell biology studies. These synergies will help deliver the strongest patient outcomes and cement the Peter Munk Cardiac Centre as an international authority in the care of heart valve disease.





PMCC HIGHLIGHTS

  • First in the world to develop the clinical use of heparin, a drug used to prevent blood clotting during and after surgery
  • Establishing of Canada’s first mechanical heart program, which serves as a bridge to transplant for patients with heart failure
  • First in the world to harvest stem cells from a patient’s bone marrow and transplant these cells into the heart during bypass surgery
  • Transforming care for adult patients born with heart defects through the Adult Congenital Heart Disease Program --- the first and largest of its kind in the world.
  • Developed the first pacemaker and the first coronary intensive care unit

FACTS ABOUT HEART DISEASE

  • #1 cause of hospitalization in Canada is heart disease
  • 90% of Canadians have at least one risk factor for heart disease
  • 1.3 million Canadians reported having heat disease in 2007

For more information, or to register, please contact
Irene Salvani at irene.salvani@uhn.ca and 647-631-5695

© Toronto General & Western Hospital Foundation
Registered Canadian Charitable Organization Number: 12386 4068 RR0001
tgwhf.ca